category,datetime,headline,id,image,related,source,summary,url
company,1768637603,Is DaVita (DVA) Pricing In Its Recent 37% One Year Share Price Gain?,138159765,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DVA,Yahoo,"If you are wondering whether DaVita's current share price fairly reflects its long term potential, you are not alone. This article will walk through what the market may be pricing in and what it might be missing. DaVita shares last closed at US$104.74, with returns of 6% over the past week, 11.6% over the past month, 8.5% year to date and 37% over the last year, set against a 30.4% return over three years and a 12.4% decline over five years. Recent market attention on DaVita has centered on...",https://finnhub.io/api/news?id=463f97fbc642df94ea9b66fcee6de66dbb233df6d1f63b535f5d6ae24ccd3e3c
company,1768623193,Is DaVita’s (DVA) Community Health Push Reframing Its Balance Between Patient Impact and Profitability?,138158507,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DVA,Yahoo,"Earlier this week, DaVita highlighted its Community Health Experience initiative, working with partners such as the American Diabetes Association and the YMCA to provide no‑cost screenings and education to underserved communities for diabetes, hypertension, and kidney disease. This focus on early detection and community outreach, combined with upcoming Q4 2025 results amid ongoing operational challenges, is drawing attention to how DaVita balances patient outcomes with cost pressures and...",https://finnhub.io/api/news?id=b5b378cf9fb0ac645bc41f764e57f2d8522f83030726cc5905d47de31b0d7df4
